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Abstract  
The skin-associated chemokine CTACK plays a key role in many inflammatory conditions 
and could be instrumental in the pathophysiology of tissue-specific immunological diseases 
such as oral lichen planus (OLP). In the present study, we investigated by RT-PCR, ELISA, 
chemotaxis assays, and fluorescence-activated cell sorting (FACS) the production of CTACK 
in oral keratinocytes, its expression in tissues from normal and OLP patients, and its role in T 
cell recruitment. CTACK was produced by the oral epithelium and it affects chemotaxis of 
memory CLA+ cells to the oral epithelium. CTACK mRNA was expressed constitutively in 
primary oral epithelium and was increased during pro-inflammatory IFN-γ treatment. We 
found a constitutive production of CTACK at a protein level in oral primary cells that 
increased after IFN-γ treatment. Moreover, we confirmed that CTACK attracts memory T 
cells and those T cells that express CLA above the level of basal migration.   
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Background  
Lichen planus (LP) is a chronic T-cell-mediated mucocutaneous inflammatory disease 
that targets the stratified epithelia. There is increasing evidence that epithelial-derived 
cytokines, immune receptors and co-stimulatory molecules promote and sustain the disease
1-
4
. Oral lichen planus, (OLP) is known to be associated with production of IFN-γ by 
infiltrating T lymphocytes. 
Cutaneous T-cell attractant chemokine CTACK, also known as CCL27, is known for its 
properties to attract memory T-cells. CTACK is highly expressed in the skin, both normal 
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The oral cavity has many immunological features in common with the skin, however the role 
of CTACK in the oral cavity immunity has yet to be investigated. Further, anti-CCL27 was 
found to be more potent than tacrolimus at reducing inflammation in skin patients, 





Aim of this study was to investigate the production of CTACK in oral keratinocytes, its 
expression in tissues from normal and OLP patients, and its role as a chemotactic molecule 
mediating T cell recruitment..  
 
Exp. design 
Three primary normal oral keratinocyte strains (NHOK1, NHOK2, NHOK3), the UP cell 
line
12
, and the H357
13
 cell line were used in this study. 
The cells were tested with TNF-α, IL-1β, and IFN-γ treatment or no treatment (for 3, 6 or 24 
hours). RT-PCR was used to assess the expression of CTACK mRNA in epithelial cell lines. 
The supernatants were also tested for the presence of the CTACK protein using ELISA. 
Peripheral blood mononuclear cells (PBMC) were prepared from fresh blood obtained from 
healthy patients.  Cell supernatants derived from the cytokine treatment assays were 
incubated with no antibody, monoclonal anti-human CTACK antibody, or mouse anti-human 
IgG2a isotype control, for 30 minutes before placing in transwell.  
Antibodies utilised to label the migrated PBL were monoclonal mouse anti-human CD45RO-
R-Phycoerythrin, monoclonal rat anti-human CLA-FITC and monoclonal mouse anti-human 
CD3 Cy-chrome. The migrated cell populations were then analysed using a florescence 
activated cell sorter (FACS) machine. 
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Results  
CTACK mRNA was expressed in primary unstimulated oral keratinocytes, and levels were 
increased when treated with IFN-γ (Fig. 1a, fig. 1b). 
The ELISA test showed a increased production of CTACK in NHOK2, and a similar trend in 
NHOK1 and 3 (Fig. 1c). However the biological triplicate showed a statistically significant 
difference (p=0.023638313) between the IFN-γ treated and non-treated cell lines. The 
average concentration produced in the IFN-γ treated cells was 557.74 pg/ml and 302.85 pg/ml 
in the unstimulated cells.  
CTACK was released from the oral carcinoma cell line, H357 in similar concentrations to the 
oral primary cell line (Fig. 1d), suggesting that H357 are an adequate study model for 
CTACK over time. CTACK was produced by untreated H357 cells but the concentration 
produced decreases over time in culture. TNF-α and IL-1β treated cells released lower 
concentrations of CTACK at 3 hours compared to the untreated cells, but the amount 
increased over each time point and was significantly increased to the untreated cells after 6 
and 24hours. IFN-γ treatment was also able to significantly increase the concentration of 
CTACK in this cell type after 24 hours (Fig. 1d).  
In the UP cell line, CTACK was detected in untreated cells at all time points. IFN-γ treatment 
slightly increased CTACK production at 3 and 24 hours compared to control cells, but not to 
a significant level. Similarly, TNF-α and IL-1β treatment increased the production of 
CTACK at 24 hours (Fig. 1d).  
The cell populations were analysed after migration with the peripheral blood lymphocyte 
population and gated upon the level of fluorescence to CD3 and CD45RO or CD3 and CLA 
into CD3+CD45RO+ cells and CD3+CD45RO+CLA+ cells (Fig. 2a, 2b). 
Recombinant human CTACK attracted memory T cell population, significantly at 100 and 
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expressing CLA from peripheral blood above the level of basal migration, to a significant 
degree at 100ng (Fig. S1). 
Both H357 and UP cell supernatants induced the migration of memory and CLA positive T 
cells above the level of basal migration in a CTACK-dependent manner (Fig. 2c, 2d). TNF-α 
and IL-1 treatment of UP and H357 cells significantly increased the migration of memory T 
cells to the extracted supernatant compared to the control. H357 cell supernatant was able to 
induce a higher migration % of memory T cells than the UP cells regardless of cell treatment. 
Pre-incubation of oral and cutaneous keratinocyte cell line supernatants with anti-CTACK 
antibody reduced the migration of memory T cells and CLA+ T cells compared to those 
untreated, and to a significant extent in TNF-α /IL-1β-treated cells. Interestingly, by blocking 
CTACK activity there was a significant increase in the migration of naïve T cells to both 
cutaneous and oral supernatants compared to those not pre-treated (Fig. 2c-2f). 
CTACK mRNA was expressed in the oral inflammatory disorder OLP and in NOM, 
however, to low levels and to differing degrees in different samples (Fig. S2). 
 
Conclusions 
CTACK is constitutively produced by oral keratinocytes, and increases during pro-
inflammatory, IFN-γ, cytokine treatment.  Further, it actively effects chemotaxis of memory 
CLA+ cells to the oral epithelium. This is the first report of a tissue-specific chemokine being 
produced by cells in the oral cavity. It suggests that CTACK may play a role in early 
recruitment of T cells that could be instrumental in the pathophysiology of tissue-specific 
immunological diseases such as oral lichen planus (OLP). 
Surprisingly, in OLP and NOM tissue, low-level CTACK mRNA was expressed in most of 
the samples tested; however, CTACK may still play a role in progressing OLP lesions and 
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Figure 1: Human keratinocytes express the chemokine CTACK in vitro. a) Expression of 
18S in the 3 epithelial cell lines non-stimulated (1-3), and treated with IFN-γ for 48hours (4-
6), and CTACK mRNA expression in these cell types are represented in lanes 7-9 and 10-12 
respectively. + represents the positive control for 18S and CTACK expression, skin cDNA. 
Lanes marked – are the negative controls for these samples.  b) Densitometric analysis of the 
average CTACK mRNA expression (normalised to 18S expression) in the 3 different primary 
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CTACK produced in primary oral epithelial cell lines (n=3) stimulated with 1000U IFN-γ 
(ifn) or left untreated for 24 hours. d) The concentration of CTACK produced (pg/ml) in the 
supernatants of H357 or UP cells treated either with IFN-γ (ifn) or TNF-α and IL-1β (TNF-α 
+IL-1β) for 3, 6 or 24 hours as determined by ELISA. Each result is the mean of triplicate 
samples ±SD. *, ** represents a significant difference p<0.05 or p<0.01 respectively between 
the treated and control cells at the same time point. 
 
Figure 2: 3 colour-FACS profile of T cells exposed to oral and cutaneous cell lines 
supernatants. The cytometry plots for the PBL population labelled with a) anti-CD3 and 
CD45RO with populations divided into CD3+CD45ROlo (R2) and CD3+CD45ROhi (R3) 
and b) anti-CD3 and CLA with gating corresponding to CD3+CLA+ (R4) or CD3+CLA- 
(R5). The normalised migration of T cell subsets to supernatants of non-treated (con) or TNF-
α and IL-1 treated (tnf+il-1) keratinocyte cell lines. The migration of CD3+CD45ROhi 
(‘memory’ T cells) or CD3+CD45ROlo (‘naïve’ T cells) to c) oral (H357) or d) cutaneous 
(UP) cell line supernatants, with or without pre-incubation with an anti-CTACK antibody 
(blocked). The migration of CLA+CD3+ or CLA-CD3+ cells to e) oral (H357) or f) 
cutaneous (UP) cell line supernatants, with or without pre-incubation with an anti-CTACK 
antibody (blocked). Basal migration is the migration of these cell types to cell culture 
medium alone. * represents a significant difference (p<0.05) in the migration induced by 
supernatants pre-treated with anti-CTACK or non-treated. 
 
Supplementary figure 1: The chemotaxis of T cells to recombinant CTACK. PBL that had 
migrated were labelled with florescent antibodies to T cell marker CD3, memory cell marker 
CD45RO and ‘skin-homing’ marker CLA. % migration is the normalised chemotaxis of a) 
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cells to 50, 100 or 150ng of CTACK (ctack 50, ctack 100 and ctack 150 respectively). Basal 
migration is the migration of cells to cell culture medium only. * represents a significant 
increase in the % migration (p<0.05) compared to basal migration.  
 
Supplementary figure 2: Expression of 18S and CTACK mRNA in OLP samples (1-8), 
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